Literature DB >> 9112705

Low back pain: a twentieth century health care enigma.

G Waddell1.   

Abstract

Despite greater knowledge, expertise, and health care resources for spinal pathologies, chronic disability resulting from nonspecific low back pain is rising exponentially in western society. Medical care certainly has not solved the everyday symptom of low back pain and even may be reinforcing and exacerbating the problem. An historic review shows that there is no change in the pathology or prevalence of low back pain: What has changed in our understanding and management. There are striking differences in health care for low back pain in the United States and the United Kingdom, although neither delivers the kind of care recommended by recent evidence-based guidelines. Medical care for low back pain in the United States is specialist-oriented, of high technology, and of high cost, but 40% of American patients seek chiropractic care for low back pain instead. National Health Service care for low back pain in the United Kingdom is underfunded, too little and too late, and 55% of British patients pay for private therapy instead. Despite the different health care systems, treatment availability, and costs, there seems to be little difference in clinical outcomes or the social impact of low back pain in the two countries. There is growing dissatisfaction with health care for low back pain on both sides of the Atlantic. Future health care for patients with nonspecific low back pain should be designed to meet their specific needs.

Entities:  

Mesh:

Year:  1996        PMID: 9112705     DOI: 10.1097/00007632-199612150-00002

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  90 in total

1.  Spine stabilisation exercises in the treatment of chronic low back pain: a good clinical outcome is not associated with improved abdominal muscle function.

Authors:  A F Mannion; F Caporaso; N Pulkovski; H Sprott
Journal:  Eur Spine J       Date:  2012-01-24       Impact factor: 3.134

2.  Pain characteristic differences between subacute and chronic back pain.

Authors:  Mona Lisa Chanda; Matthew D Alvin; Thomas J Schnitzer; A Vania Apkarian
Journal:  J Pain       Date:  2011-04-15       Impact factor: 5.820

3.  Authors' response to dr. Simons.

Authors:  Daniel Pinto; Joshua Cleland
Journal:  J Man Manip Ther       Date:  2007

4.  Psychosocial education improves low back pain beliefs: results from a cluster randomized clinical trial (NCT00373009) in a primary prevention setting.

Authors:  Steven Z George; Deydre S Teyhen; Samuel S Wu; Alison C Wright; Jessica L Dugan; Guijun Yang; Michael E Robinson; John D Childs
Journal:  Eur Spine J       Date:  2009-05-06       Impact factor: 3.134

5.  FasL on human nucleus pulposus cells prevents angiogenesis in the disc by inducing Fas-mediated apoptosis of vascular endothelial cells.

Authors:  Zhen Sun; Zhong-Yuan Wan; Yun-Shan Guo; Hai-Qiang Wang; Zhuo-Jing Luo
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

6.  Back surgery: Modern medical pitfall.

Authors:  Jc Smith
Journal:  J Chiropr Med       Date:  2002

7.  Meta-Analysis of Thirty-Four Independent Samples Studied Using PET Reveals a Significantly Attenuated Central Response to Noxious Stimulation in Clinical Pain Patients.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

8.  Spinal supports and physical therapy in patients with low back pain: a case series.

Authors:  Vinod K Podichetty; Eric S Varley
Journal:  BMJ Case Rep       Date:  2009-04-23

9.  MiR-34a promotes Fas-mediated cartilage endplate chondrocyte apoptosis by targeting Bcl-2.

Authors:  Huajiang Chen; Jianxi Wang; Bo Hu; Xiaodong Wu; Yu Chen; Renhu Li; Wen Yuan
Journal:  Mol Cell Biochem       Date:  2015-04-25       Impact factor: 3.396

10.  Subacute and chronic, non-specific back and neck pain: cognitive-behavioural rehabilitation versus primary care. A randomized controlled trial.

Authors:  Odd Lindell; Sven-Erik Johansson; Lars-Erik Strender
Journal:  BMC Musculoskelet Disord       Date:  2008-12-30       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.